Efficacy of Donepezil in Patients With Chronic Tinnitus

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 19, 2021

Primary Completion Date

December 9, 2025

Study Completion Date

December 9, 2025

Conditions

Tinnitus

Interventions

DRUG

Donepezil group

Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months

DRUG

Placebo group

35 Pacients with tinnitus received for 3 months placebo medication

Trial Locations (1)

Universidade De São Paulo, São Paulo

All Listed Sponsors

collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT07153991 - Efficacy of Donepezil in Patients With Chronic Tinnitus | Biotech Hunter | Biotech Hunter